The FDA notice states there is a "reasonable probability for serious adverse events, including death" if a patient receives an intravenous infusion of product containing particulate matter. The same day, Baxter International recalled a lot of Cefazolin in Dextrose Injection, an intravenous antibiotic, after particulate matter identified as cardboard was found in the solution. Cyclophosphamide treats cancers including lymphoma, leukemia, multiple myeloma, breast and ovarian cancer, and is also used in certain autoimmune and kidney conditions. Three recalls on one day does not establish a trend, and the FDA posts recall notices continuously across all drug categories. Particulate Matter Is a Recurring Failure ModeTwo of these three recalls involve visible foreign material, in one case steel and in the other cardboard.